{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-024505","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.289108+00:00","generated_at":"2026-05-24T15:44:27.898183+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"confidence":"high","headline":"Nasdaq to delist Avenue Therapeutics on March 19; stock to trade on OTC Markets","bullets":["Nasdaq notified Company it will delist common stock effective at open on March 19, 2025.","Delisting due to failure to maintain minimum $2.5M stockholders' equity per Nasdaq Rule 5550(b)(1).","Company failed to meet conditions of Panel exception requiring disclosure of equity-increasing transactions by March 14.","Common stock (ATXI) expected to begin trading on OTC Markets on March 19, 2025.","Company will continue filing periodic reports with SEC but warns of uncertain trading liquidity."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-024505","json":"https://secwatch.observer/filing/0001104659-25-024505.json","markdown":"https://secwatch.observer/filing/0001104659-25-024505.md","text":"https://secwatch.observer/filing/0001104659-25-024505.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/0001104659-25-024505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/tm259546d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T15:44:27.898183+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}